Method for Scalp Cooling Now Offered to More Patients – Reduces Hair Loss in Cancer Patients
The Aleris Oncology Clinic at Sabbatsberg Hospital, Stockholm - Sweden is expanding access to an innovative scalp cooling treatment for cancer patients after a successful pilot project in collaboration with Dignitana.
“We have observed improvements in our patients’ psychosocial well-being,” says Anna-Maria Hasselgren Häll, oncology nurse at Aleris Christinakliniken.
Aleris has conducted a series of extensive trials on an innovative scalp cooling treatment that reduces hair loss in cancer patients undergoing chemotherapy for solid tumors. Patients beginning chemotherapy will now be offered the option to use scalp cooling.
“Being able to retain hair during cancer treatment is not just about appearance. Patients often express how important it is to keep their hair for self-esteem and everyday life,” says Anna-Maria Hasselgren Häll.
By lowering the temperature in the scalp, blood flow and metabolism are reduced, causing hair follicles to absorb less of the chemotherapy drugs. This allows patients to retain their hair to a greater extent during challenging treatments, which significantly enhances their quality of life and well-being.
The scalp cooling treatment was developed by the medical technology company Dignitana. A personalized cap is connected to the DigniCap Delta machine, which cools the patient’s scalp during chemotherapy. This has proven to be highly effective in reducing hair loss.
“We have a close collaboration with Aleris Christinakliniken, which was quick to recognize the value of this treatment for their patients. I am very pleased that they are now taking this forward, giving as many people as possible the chance to preserve their hair and feel better,” says Fredrik Jonsson, CEO of Dignitana.
Aleris Christinakliniken has now chosen to permanently offer Dignitana’s DigniCap Delta to meet demand and enhance the quality of cancer care. Aleris expects that this initiative will enable more cancer patients to receive support in connection with their chemotherapy. There is significant demand for this treatment, with patients from across Sweden reaching out directly to the clinic or Dignitana.
“We often receive calls from patients wanting to know where they can access scalp cooling treatment. It is therefore very gratifying that Aleris Christinakliniken wants to make this treatment more widely available. In the long term, scalp cooling should be an integrated part of modern cancer care,” says Fredrik Jonsson at Dignitana.
Every year, approximately 72,000 people in Sweden are diagnosed with cancer, of which over 8,000 are breast cancer cases [1]. The number of cancer cases in Sweden has increased over the last fifty years, although mortality has decreased during the same period. This is largely due to advances in research, improved early detection, better treatment options, and lifestyle changes.
For more information, contact:
Anna-Maria Hasselgren Häll, Licensed Oncology Nurse and Head of Unit at Aleris Christinakliniken, +46 730 38 38 20 (press service), anna-maria.hasselgren-hall@aleris.se
Fredrik Jonsson, CEO of Dignitana AB (publ), +46 708 76 64 44, fredrik.jonsson@dignitana.com
About Aleris Christinakliniken:
The Aleris Oncology Clinic specializes in cancer care, focusing on breast diagnostics, treatment, and follow-up of breast cancer. Our team includes a professor, an associate professor, and several oncology specialists, and at the clinic, you’ll meet our oncology nurses with specialist knowledge in cancer care.
For More Information Contact
Fredrik Jonsson, CEO, fredrik.jonsson@dignitana.com +46 708766444
About Dignitana
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.